Azitra, Inc. SEC filings AZTR

Azitra, Inc. has 237 filings in SEC EDGAR's recent list, going back to Mar 20, 2017. Its latest annual report, Form ARS, was filed on May 8, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (other events). The company's fiscal year ends on December 31.

Azitra, Inc. SEC filings
Form Description Filed Period
SCHEDULE 13G Ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Jun 25, 2026 —
SCHEDULE 13D Ownership over 5% (active) Jun 24, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Jun 22, 2026 —
4 Insider transaction Jun 18, 2026 Jun 16, 2026
4 Insider transaction Apr 22, 2026 Apr 20, 2026
4 Insider transaction Apr 22, 2026 Apr 20, 2026
4 Insider transaction Apr 22, 2026 Apr 20, 2026
4 Insider transaction Mar 20, 2026 Mar 18, 2026
4 Insider transaction Dec 22, 2025 Dec 19, 2025
4 Insider transaction Dec 22, 2025 Dec 19, 2025
4 Insider transaction Dec 22, 2025 Dec 19, 2025
4 Insider transaction Dec 22, 2025 Dec 19, 2025
4 Insider transaction Dec 22, 2025 Dec 19, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Dec 19, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Aug 20, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
SCHEDULE 13G Ownership over 5% (passive) May 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 6, 2024 —
144 Notice of proposed sale Sep 16, 2024 —
SC 13D/A Amended ownership over 5% (active) Aug 2, 2024 —
SC 13G Ownership over 5% (passive) Aug 1, 2024 —
SC 13G Ownership over 5% (passive) Jul 29, 2024 —
4 Insider transaction Apr 1, 2024 Mar 29, 2024
SC 13G Ownership over 5% (passive) Feb 27, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 26, 2024 —
SC 13G Ownership over 5% (passive) Feb 26, 2024 —
4 Insider transaction Feb 15, 2024 Feb 13, 2024
4 Insider transaction Feb 15, 2024 Feb 13, 2024
4 Insider transaction Feb 15, 2024 Feb 13, 2024
SC 13G Ownership over 5% (passive) Feb 12, 2024 —
4 Insider transaction Oct 3, 2023 Sep 8, 2023
4 Insider transaction Oct 3, 2023 Sep 8, 2023
4 Insider transaction Oct 3, 2023 Sep 8, 2023
4 Insider transaction Oct 3, 2023 Sep 8, 2023
4 Insider transaction Jul 24, 2023 Jun 21, 2023
3 Initial insider ownership Jul 24, 2023 Jun 15, 2023
SC 13D Ownership over 5% (active) Jul 3, 2023 —
4/A Filing Jun 29, 2023 Jun 23, 2023
4 Insider transaction Jun 26, 2023 Jun 21, 2023
4 Insider transaction Jun 23, 2023 Jun 21, 2023
4 Insider transaction Jun 23, 2023 Jun 21, 2023
4 Insider transaction Jun 23, 2023 Jun 21, 2023
4 Insider transaction Jun 23, 2023 Jun 21, 2023
3 Initial insider ownership Jun 15, 2023 Jun 15, 2023
3 Initial insider ownership Jun 15, 2023 Jun 15, 2023
3 Initial insider ownership Jun 15, 2023 Jun 15, 2023
3 Initial insider ownership Jun 15, 2023 Jun 15, 2023
3 Initial insider ownership Jun 15, 2023 Jun 15, 2023
3 Initial insider ownership Jun 15, 2023 Jun 15, 2023
3 Initial insider ownership Jun 15, 2023 Jun 15, 2023
3 Initial insider ownership Jun 15, 2023 Jun 15, 2023

Showing 58 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
AZTR (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Branford, CT
SEC filer status
, Emerging growth company
SEC CIK
1701478
Former names
Azitra Inc (until Jan 4, 2024)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.